Edition:
United Kingdom

People: Cytokinetics Inc (CYTK.OQ)

CYTK.OQ on NASDAQ Stock Exchange Global Select Market

13.26USD
16 Aug 2019
Change (% chg)

-- (--)
Prev Close
$13.26
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
162,975
52-wk High
$14.17
52-wk Low
$5.76

Blum, Robert 

Mr. Robert I. Blum is President, Chief Executive Officer, Director of the Company. Mr. Blum served as our President from February 2006 to January 2007. He served as our Executive Vice President, Corporate Development and Commercial Operations and Chief Business Officer from September 2004 to February 2006. From January 2004 to September 2004, he served as our Executive Vice President, Corporate Development and Finance and Chief Financial Officer. From October 2001 to December 2003, he served as our Senior Vice President, Corporate Development and Finance and Chief Financial Officer. From July 1998 to September 2001, Mr. Blum was our Vice President, Business Development. Prior to joining us in July 1998, he was Director, Marketing at COR Therapeutics, Inc. since 1996. From 1991 to 1996, he was Director, Business Development at COR Therapeutics. Prior to that, Mr. Blum performed roles of increasing responsibility in sales, marketing and other pharmaceutical business functions at Marion Laboratories, Inc. and Syntex Corporation. Mr. Blum received B.A. degrees in Human Biology and Economics from Stanford University and an M.B.A. from Harvard Business School.

Basic Compensation

Total Annual Compensation, USD 961,667
Restricted Stock Award, USD 431,586
Long-Term Incentive Plans, USD --
All Other, USD 1,474,590
Fiscal Year Total, USD 2,867,840

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leonard Patrick Gage

291,926

Robert Blum

2,867,840

Ching Jaw

1,099,890

Fady Malik

1,219,940

David Cragg

388,209

Robert Wong

--
As Of  31 Dec 2017